Ó³»­´«Ã½

The PCL combines Ó³»­´«Ã½â€™s innovative methods for basic scientific discovery and the clinical expertise of its practicing physician/researchers with Bayer’s long history of drug discovery and development. Physically located at the Ó³»­´«Ã½, the PCL consists of scientists from the Ó³»­´«Ã½ and Bayer working together toward a shared scientific vision.

The initial goal of the PCL is to characterize individual cells from human tissue samples and preclinical animal models in health and disease. These high-resolution, single cell maps will broaden our understanding of underlying disease mechanisms and facilitate the development of new therapeutic interventions.